Seeing Is Believing
with an average price target of $2.61. This is a potential upside of $2.61 (0%) from yesterday's end of day stock price of $0.
Dicerna Pharmaceuticals's activity chart (see below) currently has 91 price targets and 57 ratings on display.
Analysts average stock forecasts to be materialized ratio is 75.96% with an average time for these price targets to be met of 309.55 days.
Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 08-Dec-2021. First documented stock forecast 13-Mar-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$28
$-10.22 (-26.74%)
3 years 1 months 21 days ago
(08-Dec-2021)
1/2 (50%)
$-10 (-26.32%)
101
Buy
$30
$-8.22 (-21.51%)
$30
3 years 2 months 11 days ago
(19-Nov-2021)
2/3 (66.67%)
$-7.92 (-20.89%)
250
Hold
$35
$-3.22 (-8.42%)
$35
3 years 2 months 11 days ago
(18-Nov-2021)
3/6 (50%)
$-3.03 (-7.97%)
168
Hold
$38
$-0.22 (-0.58%)
$42
3 years 2 months 11 days ago
(18-Nov-2021)
8/10 (80%)
$-0.03 (-0.08%)
260
Hold
$25
$-13.22 (-34.59%)
3 years 5 months 18 days ago
(11-Aug-2021)
5/9 (55.56%)
$3.71 (17.43%)
195
What is DRNA (Dicerna Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on DRNA (Dicerna Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on DRNA (Dicerna Pharmaceuticals)?
Which analyst is the currently most bullish on DRNA (Dicerna Pharmaceuticals)?
Which analyst is the currently most reserved on DRNA (Dicerna Pharmaceuticals)?